Data from our Partners.
View the latest data from our partners demonstrating how IRO® is helping to accelerate their cell therapy product development processes.
Charles River Laboratories (CRL).
Ori Biotech and CRL Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing.
View data from our collaboration with Charles River Laboratories

"The test of Ori’s new IRO platform using head-to-head process transfer runs shows promising results... and helps to address the manufacturing bottleneck challenge."

Matthew Hewitt, B.A. PhD
Vice President, CTO Manufacturing Business Division, Charles River
CTMC.
Ori Biotech and CTMC Present Scientific Data for New IRO® Platform at ISCT 2024
View biological performance data generated by Ori Biotech partner CTMC

"I expected automation, I expected more process insights, but I never expected better biological performance right out of the gate."

Jason Bock
Co-Founder and CEO, CTMC, A joint venture between Resilience + MD Anderson Cancer Center
ElevateBio.
IRO® Evaluation by ElevateBio: Key Results.
View ElevateBio data comparing the IRO to an industry standard control

"The IRO's intuitive design streamlines training and operation, enabling rapid adoption and immediate productivity.”"

Jeff Cram
Senior Director, Cellular Process Development
Oribiotech Ltd 2025 © All rights reserved.
Oribiotech Ltd is registered in England and Wales. "Ori”, “Ori Biotech”, "Iro" and the O icon are registered trademarks of Oribiotech Ltd.
Company registration 09757696.